Skip to content, navigation or search.

Find a Cure

Search our online library:

Find a Doc

Find a doctor who practices alternative, natural or complementary medicine in your state! Click here to get started.

Coincidence, or fishy timing? It looks like the FDA might have given Pfizer the gift of two lucrative years

I’m not a conspiracy theorist. But if I were, I would find this timing very fishy.

While I was doing some research, I couldn’t help but notice three dates.

See what you think…

* In early 2010, I told you about the first published studies confirming a link between the use of statin drugs and increased type 2 diabetes risk.

* Almost two years later, in December 2011, Pfizer’s patent for Lipitor ended. Lipitor, of course, is the original patented statin and the best selling drug ever.

* Then, about two months later, in early 2012, the FDA finally issued a requirement for statin drugs to list diabetes risk.

Hmmm. Did the FDA do Pfizer a huge favor by holding off on the diabetes warning for two years?

I’ll answer that one with a question… If we found out the FDA did exactly that, would we be one bit surprised?

Get urgent health alerts, warnings and insights delivered straight to your inbox

Health Disclaimer! The information provided on this site should not be construed as personal medical advice or instruction. No action should be taken based solely on the contents of this site. Readers should consult appropriate health professionals on any matter relating to their health and well-being. The information and opinions provided here are believed to be accurate and sound, based on the best judgment available to the authors, but readers who fail to consult appropriate health authorities assume the risk of any injuries. The publisher is not responsible for errors or omissions.